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INTRODUCTION
Cervical lymph node metastasis is frequently encountered on neck CT of patients with squamous cell carcinoma (SCC) and non-squamous cell carcinoma (non-SCC). The presence of lymph node metastasis is a well-known adverse prognostic factor in patients with head and neck cancers. Accurate information about cervical lymph node metastases is essential for choosing the most appropriate treatment. Imaging plays a critical role in addition to clinical evaluation towards improving the detection of nodal metastases. The most commonly used radiologic criteria to detect cervical lymph node metastasis on neck CT is the short axis diameter (> 1 cm). Morphologic features such as ne-crosis and indistinct margins have improved the detection of lymph node metastasis on neck CT. However, it is often difficult to diagnose cervical lymph node metastasis on neck CT. Metastasis in normal-sized lymph nodes can be missed and reactive lymph node enlargement cannot be reliably differentiated from metastatic involvement. Tuberculous lymphadenitis with intranodal necrosis can mimic metastatic lymphadenopathy. Therefore, numerous studies have been performed on the differential diagnosis between cervical lymph node metastasis and nonmetastatic lymph node conditions on neck CT (1) (2) (3) (4) .
To the best of our knowledge, no prior published report has discussed the role of enhanced neck CT in differential diagnosis between SCC and non-SCC. SCC is the most common histolog-Non-SCCs included 23 adenocarcinomas, 2 malignant neuroendocrine tumors, 2 medullary thyroid carcinomas, 20 papillary thyroid carcinomas, 1 salivary duct carcinoma, 1 small cell carcinoma, and 1 undifferentiated carcinoma.
Computed Tomography
All CT scans were performed with 8 channel (GE LightSpeed Ultra; GE Medical Systems, Waukesha, WI, USA) and 64 channel (GE LightSpeed VCT; GE Healthcare, Milwaukee, WI, USA) equipments. Scanning parameters were as follows: 1 table pitch, 120 kVp, 140 mAs, and 5 mm thickness. After acquisition of unenhanced images, 100 mL of nonionic contrast material (Iomeron 350; Braco, Milan, Italy/Omnipaque 350; Nycomed, Oslo, Norway/GE Healthcare, Milwaukee, WI, USA) was injected at 1.5 mL/s followed by a 20 mL saline flush.
Image Analysis
A head and neck radiologist with 9 years experience (Observer 1) and a radiology resident (Observer 2) independently reviewed two sets (SCC and non-SCC) of neck CT. Two observers were asked to assess the characteristics of the abnormal lymph nodes (number, margin types, enhancement patterns, size, bilaterality, calcification, fat infiltration, conglomeration, invasion of adjacent tissue, and nodal distribution).
Observers counted the total number of abnormal lymph nodes greater than 1 cm in the short diameter identified on neck CT.
Enlarged lymph nodes with normal fatty hilum or normal ovoid shape (long to short axis ratio > 2) were considered to be reactive lymph nodes, even if the size of the lymph node was larger than 1 cm. The observers counted "conglomerate" nodal metastasis as one metastatic lymph node. Following the 'N' staging of the American Joint Committee on Cancer 6th edition TNM staging manual, the specific 'count' was considered to have minimal sig-ic type found in cervical lymph node metastasis followed by adenocarcinoma. Adenocarcinoma is the most common histological type in cervical lymph node metastasis from non-SCC. Differential diagnosis of SCC and non-SCC is important, because the treatment plan and prognosis are significantly different between the two disease conditions. Radiologic differential diagnosis is especially helpful and reliable when histologic examination is difficult or impossible. It is not always possible to obtain a definite pathologic confirmation. Reasons for not having confirmed pathologic diagnosis include indeterminate biopsy specimen in spite of repeated trials or inability to tolerate the procedure. Additional information about the cell type in nodal metastases is essential for choosing the most appropriate treatment in patients with lymph node metastasis without a definite primary site of origin. The chemotherapy regimen varies depending on the histologic type of cancer. The 5-year overall survival rate of patients with SCC that has metastasized to the cervical lymph nodes is about 68.5%. The survival rate of patients with metastatic non-SCC in the cervical lymph nodes is lower than that in patients with metastatic SCC in the cervical lymph nodes. The 5-year overall survival rate of patients with adenocarcinoma is about 9%.
The purpose of our study was to assess the differential imaging findings of metastatic lymph nodes in SCC and non-SCC on neck CT and to facilitate the identification of primary focus before performing a biopsy.
MATERIALS AND METHODS

Patients
We retrospectively analyzed 46 patients ( nodes with each margin type to total lymph nodes, the ratio of lymph nodes with each enhancement pattern to total lymph nodes, the diameter of the largest lymph node, the number of lymph nodes in each group, and patient age between the two cancer groups. The chi-square test was used to compare bilaterality, presence of calcification, fat infiltration, conglomeration, invasion of adjacent tissue, and patient sex between the two cancer groups. The independent t-test was also used to compare the nodal distribution between the two groups. Considering the high proportion of cases with thyroid cancer in the non-SCC group, an additional analysis was performed between the SCC group and the non-SCC group, except for cases of thyroid cancer. In order to exclude the influence of thyroid cancer, independent t-test and chi-square test were additionally applied to variables that showed a significant difference between the SCC and non-SCC groups.
Inter-observer agreement was evaluated using intraclass cor- 
RESULTS
The results were significantly different between the two ob-nificance with large mass potentially representing multiple matted lymph nodes (1) . The margin of the lymph nodes was classified as well-defined smooth, well-defined irregular, or ill-defined. Observers counted the number of each type of lymph node and calculated the ratio of each type of lymph node to the total number of lymph nodes assessed. The number of lymph nodes in the non-SCC group was significantly greater than that in the SCC group (p < 0.05) ( Tables 1, 2 ).
The number of lymph nodes smaller than 3 cm was significantly greater in the non-SCC group than in the SCC group (p < 0.05).
With respect to the non-necrotic lymph nodes, the ratio of servers with respect to the ratio of lymph nodes with ill-defined margins to total lymph nodes, the ratio of lymph nodes with thick irregular wall enhancement to total lymph nodes, the number of lymph nodes larger than 6 cm in size, and invasion of adjacent tissue. Statistical results of these items are marked as 'not available' in this article.
Between the SCC group and the non-SCC group except for cases of thyroid cancer, the number of lymph nodes and the number of lymph nodes smaller than 3 cm in the non-SCC group except for cases of thyroid cancer were significantly greater than those in the SCC group (p < 0.05). There was no significant difference in the ratio of lymph nodes with heterogeneous enhancement to total lymph nodes, the ratio of lymph nodes with thick irregular wall enhancement to total lymph nodes, age, incidence of calcification, and adjacent tissue invasion between the SCC group and the non-SCC group, except for cases of thyroid cancer.
lymph nodes with heterogeneous enhancement to total lymph nodes in the non-SCC group was significantly greater than that in the SCC group (p < 0.05) ( Fig. 1 ). Among the necrotic lymph nodes analyzed, the ratio of lymph nodes with thick irregular wall enhancement to total lymph nodes in the SCC group was significantly higher than that in the non-SCC group (p < 0.05) (Fig. 2) . The patients in the SCC group were significantly older than those in the non-SCC group (p < 0.05).
The incidence of calcification was significantly higher in the non-SCC group than in the SCC group (p < 0.05) (Fig. 3) . The incidence of adjacent tissue invasion in the non-SCC group was significantly higher than that in the SCC group (p < 0.05) (Tables 3, 4).
There was no significant difference in the ratio of lymph nodes with each margin type to total lymph nodes, the diameter of the largest lymph node, bilaterality, fat infiltration, and conglomeration between the two groups ( Figs. 4, 5 ).
The number of lymph nodes larger than 6 cm in size and the number of level IIA, VI, and paratracheal groups of lymph nodes were too small to draw statistical conclusions. For example, there were only three lymph nodes larger than 6 cm in size in both groups (1 in the SCC group, 2 in the non-SCC group). The number of lymph nodes in the non-SCC group and the number of lymph nodes smaller than 3 cm were greater than those in the SCC group. There also were significant differences between the SCC group and the non-SCC group except for cases of thyroid cancer. Conglomeration of at least three lymph nodes has been used as a morphologic criteria for the diagnosis of SCC of the head and neck region (5, 6) . In this study, we counted "conglomerate" nodal metastasis as one lymph node with metastatic involvement and conglomeration was more frequently observed in the SCC group (55.6%) than in the non-SCC group (44.4%). As the conglomeration of lymph nodes increases, the number of total lymph nodes may decrease, similar to a negative correlation. The higher frequency of lymph node conglomeration in the SCC group may have resulted in counting of a larger number of metastatic lymph nodes in the non-SCC group than in the SCC group.
To the best of our knowledge, there has been no report that compared the characteristics of lymph nodes with heterogeneous enhancement between the SCC and non-SCC groups. In our study, the ratio of lymph nodes with heterogeneous enhancement to total lymph nodes was significantly larger in the non-SCC group than in the SCC group. However, there was no significant difference in the ratio of lymph nodes with heteroge- (7) . Cystic metastasis with thin regular wall enhancement has not been commonly reported (9) (10) (11) (12) (13) .
Goldenberg previously stated that cystic metastasis with thin regular wall enhancement can be explained by a malignant process in the lymphoepithelial tissue of Waldeyer's ring or a relationship with human papillomavirus in tonsil/tongue SCC (14, 15) . Regauer et al. (16) reported that cystic change can be present at a microscopic level in as many as 50% of metastasis from a primary SCC in the Waldeyer' s ring. In our study, thin regular wall enhancement of SCC was noted in 17% of the cases (13/46).
There was a significant difference in counting of the number of lymph nodes larger than 6 cm in size between the two ob- Biopsy was performed only on a few selected lymph nodes in patients with multiple cervical lymph node metastases. In conclusion, large number of lymph nodes, heterogeneous enhancement pattern, large number of lymph nodes smaller than 3 cm in size, presence of calcification, and presence of adjacent tissue invasion suggest non-SCC rather than SCC. The presence of thick irregular wall enhancement pattern in lymph nodes with metastasis suggests SCC rather than non-SCC. The age of patients in the SCC group was higher than that of patients in the non-SCC group. SCC was more frequent in men than in women, and non-SCC was relatively more frequent in women than in men. Lymphadenopathies associated with SCC were more common in levels IA, IB, and III groups of lymph nodes, while lymphadenopathies associated with non-SCC were more common in levels IIB and IV groups of lymph nodes on neck CT.
In conclusion, the number of lymph nodes, the number of lymph nodes smaller than 3 cm, and nodal distribution are helpful in differential diagnosis between SCC and non-SCC before performing a biopsy.
cell types in the non-SCC group with adjacent tissue invasion included papillary thyroid carcinoma, medullary thyroid carcinoma, adenocarcinoma, and salivary duct carcinoma. Papillary carcinoma was the predominant tumor type in the non-SCC group with adjacent tissue invasion (7/21, 33.3%). As a result, there was no significant difference in adjacent tissue invasion between the SCC group and the non-SCC group except for cases of thyroid cancer. Yamashita et al. (32, 33) result. There was no significant difference in age between the SCC group and the non-SCC group except for cases of thyroid cancer. Thyroid cancer can occur at any age but it often affects younger patients. The median age at the time of diagnosis of thyroid cancer was 50 years in a previous study (34, 35) . In our study, the mean age of patients with primary thyroid cancer in the non-SCC group was 52 years.
In our study, SCC was more frequent in men than in women (female to male ratio, 11:35) and non-SCC was relatively more frequent in women than in men (female to male ratio, 29:21).
Thyroid cancer was noted in 22 patients, who accounted for a high proportion of non-SCC cases (22/50). Thyroid cancer was much more frequent in females than in males (female to male ratio, 18:4). In the previous reports, Parkin and Muir (34) and
Voutilainen et al. (35) stated that the female-to-male ratio of thyroid cancer ranged from 2:1 to 5:1 in most populations. The higher frequency of non-SCC in women than in men was suspected to be due to the high proportion of thyroid cancer cases in the non-SCC group.
This study had several limitations. First, the total sample size
